The Effect of Short-term Supplementation of OliPhenolia® on Fat Oxidation.

NCT ID: NCT07210099

Last Updated: 2025-10-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-30

Study Completion Date

2026-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is current research interest in the use of fruit and plant-based food products containing high levels of natural antioxidants and their impact on exercise, which may be particularly beneficial for recreationally or low-active populations. One such product is an olive extract drink (called OliPhenolia®) produced by Fattoria La Vialla (an organic farm based in Northern Italy) and commercially available for the general public. Whilst previous research from the investigators (at Anglia Ruskin University) using this product has demonstrated potential antioxidant benefits and reduced oxygen cost during aerobic exercise, there are to date no studies investigating whether the short-term consumption of OliPhenolia® can benefit fat oxidation during exercise or whether such effects can be further enhanced employing a pre workout caffeinated beverage.

Therefore the aim of this study is two-fold:

i) to assess the impact of short-term supplementation (8 days) of OliPhenolia® relative to body mass on fat oxidation during aerobic cycling exercise in comparison to placebo in healthy recreationally active volunteers; and ii) whether potential benefits of OliPhenolia® on fat oxidation are enhanced with a pre-workout caffeinated beverage in comparison to placebo in healthy recreationally active volunteers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This exploratory study will involve initial recruitment of approximately 30-40 healthy volunteers to undertake an initial study briefing pre-screening health questionnaire, informed written consent and familiarisation to exercise equipment, before returning to the human physiology laboratory at Anglia Ruskin University on a separate occasion (Visit 1) to undertake a standard exercise test for maximal fitness capacity.

Following this, Visit 2 will see participants undertake a standard fat oxidation exercise test (aerobic exercise on a cycle ergometer) to ascertain maximal fat oxidation (Fatmax) with increasing exercise intensity, as well as a steady state exercise bout (30mins at FATmax).

After this participants will begin a short-term (8 days) supplementation period of either OliPhenolia or Placebo before returning for a follow up fat oxidation assessment (Visit 3) as above. Fat oxidation will be assessed by standard respiratory measures (breath to breath for oxygen and carbon dioxide). On the follow up test (Visit 3), a pre-exercise workout drink will be provided containing either caffeine flavoured water or placebo. This is to assess whether fat oxidation can be enhanced from short-term polyphenol supplementation (OliPhenolia) with or without additional caffeine prior to exercise.

Participants will therefore be randomised into 1 of 4 groups for this study (Placebo product for 8 days + placebo beverage at follow up; Oliphenolia for 8 days + placebo beverage at follow up; and OliPhenolia for 8 days plus caffeinated beverage at follow up; and placebo product for 8 days plus caffeinated beverage at follow up).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Participants will be randomly assigned to one of the 2 main experimental groups in a double-blinded manner. Following completion of the first round of testing, those participants consuming OliPhenolia will return after a 1 week wash out period and repeat the process but taking placebo, and vice versa. Therefore all participants will have consumed either test product or placebo. For the pre-follow up test beverage, participants will be randomly assigned to either placebo or caffeine in block manner. This exploratory study will only involve a single cross over.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Participants Investigators
Supplements (product, placebo and product and product + caffeine) will be provided in a randomized, double-blinded manner. Both the participants and research testers will be masked from knowing the specifics of the supplement intervention.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

OliPhenolia® plus placebo beverage

OliPhenolia® is to be consumed twice daily, away from food and separated by ≥4 hours, for a period of 8 days.

Note each serving of OliPhenolia® is a volume equivalent to ≤1.0mg∙kg-1 of Hydroxytyrosol.

At the follow up test participants will also be provided with a 150mL placebo (microcrystalline cellulose at a dose of 6mg/kg) beverage pre-exercise.

Group Type EXPERIMENTAL

Concentrated olive fruit water

Intervention Type DIETARY_SUPPLEMENT

Supplementation of OliPhenolia twice daily for eight days. Dose equivalent to ≤1.0mg∙kg-1 of hydroxytyrosol.

Placebo beverage

Intervention Type DIETARY_SUPPLEMENT

A single bolus of flavoured water (150mL) containing 6mg/kg microcrystalline cellulose

Placebo product plus placebo beverage

A taste and appearance matched placebo will be used within this research, conforming to the recipe utilised in previously published OliPhenolia® research. Recipe as follows; equal ratio \[1:1:1\] of prune juice, diet cola, and tonic water. The placebo formula will be provided in matched 28mL sterilised jars provided order to match OliPhenolia® original packaging.

At the follow up test participants will also be provided with a 150mL placebo (microcrystalline cellulose at a dose of 6mg/kg) beverage pre-exercise.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

Placebo matched for taste and appearance consumed twice daily for eight days in the equivalent volume to the experimental product.

Placebo beverage

Intervention Type DIETARY_SUPPLEMENT

A single bolus of flavoured water (150mL) containing 6mg/kg microcrystalline cellulose

OliPhenolia® +Caffeine (pre workout)

OliPhenolia® is to be consumed twice daily, away from food and separated by ≥4 hours, for a period of 8 days.

Note each serving of OliPhenolia® is a volume equivalent to ≤1.0mg∙kg-1 of Hydroxytyrosol.

For the pre workout beverage this will be a single serve drink (150mL) containing flavoured water with 6mg/kg anhydrous caffeine based on previous research. The product will only be used pre-exercise as a single bolus.

Group Type EXPERIMENTAL

Concentrated olive fruit water

Intervention Type DIETARY_SUPPLEMENT

Supplementation of OliPhenolia twice daily for eight days. Dose equivalent to ≤1.0mg∙kg-1 of hydroxytyrosol.

Anhydrous caffeine

Intervention Type DIETARY_SUPPLEMENT

A single bolus of flavoured water (150mL) containing 6mg/kg anhydrous caffeine taken as a pre-exercise beverage

Placebo +Caffeine (pre workout)

A taste and appearance matched placebo will be used within this research, conforming to the recipe utilised in previously published OliPhenolia® research. Recipe as follows; equal ratio \[1:1:1\] of prune juice, diet cola, and tonic water. The placebo formula will be provided in matched 28mL sterilised jars provided order to match OliPhenolia® original packaging.

For the pre workout beverage this will be a single serve drink (150mL) containing flavoured water with 6mg/kg anhydrous caffeine based on previous research. The product will only be used pre-exercise as a single bolus.

Group Type ACTIVE_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

Placebo matched for taste and appearance consumed twice daily for eight days in the equivalent volume to the experimental product.

Anhydrous caffeine

Intervention Type DIETARY_SUPPLEMENT

A single bolus of flavoured water (150mL) containing 6mg/kg anhydrous caffeine taken as a pre-exercise beverage

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Concentrated olive fruit water

Supplementation of OliPhenolia twice daily for eight days. Dose equivalent to ≤1.0mg∙kg-1 of hydroxytyrosol.

Intervention Type DIETARY_SUPPLEMENT

Placebo

Placebo matched for taste and appearance consumed twice daily for eight days in the equivalent volume to the experimental product.

Intervention Type DIETARY_SUPPLEMENT

Anhydrous caffeine

A single bolus of flavoured water (150mL) containing 6mg/kg anhydrous caffeine taken as a pre-exercise beverage

Intervention Type DIETARY_SUPPLEMENT

Placebo beverage

A single bolus of flavoured water (150mL) containing 6mg/kg microcrystalline cellulose

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

OliPhenolia

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women, UK based, above 21 years of age with a body mass index (BMI) \>18 and \<30 kg·m2 determined during baseline testing

* Considered to be recreationally active i.e. approximately 150mins of general physical activity/ exercise per week (meeting the WHO physical activity guidelines); and a VO2peak (fitness) score \>20 and \<50 mL·kg-1·min-1 determined during baseline testing.
* No known history (including family history) of heart abnormalities, hypertension, coronary heart disease or diabetes (determined from pre-study health screen questionnaire).
* Not currently suffering from any musculoskeletal injury, or any other reason that may prevent participation in cardiovascular exercise.
* Have not suffered from recent viral infections ie: influenza (defined within the prior 2 months).
* Not taking any prescribed or over-the-counter medication which may influence exercise training (with the exception of inhalers for exercise induced asthma or contraceptive pill).
* Not consuming or prepared to refrain from consumption, any commercial supplementation which conflicts with the study parameters ie: antioxidants.
* No known allergy or intolerance to olives or prune/grape juice, or any known side effects from caffeine ingestion.

Exclusion Criteria

* If any of the above criteria is not met.
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Anglia Ruskin University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Justin Roberts

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Justin D Roberts, Professor

Role: PRINCIPAL_INVESTIGATOR

Anglia Ruskin University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cambridge Centre for Sport and Exercise Sciences, Anglia Ruskin University,

Cambridge, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Justin D Roberts, Professor

Role: CONTACT

07794122020

Joseph B Lillis

Role: CONTACT

07713870153

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Justin D Roberts, PhD

Role: primary

07794122020

Joseph B Lillis, MSc

Role: backup

07713870153

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ETH2425-5668

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Caffeine Kinetics and CrossFit®-Specific Performance
NCT05516212 RECRUITING PHASE2/PHASE3